CIK 0001411685 · Non-accelerated filer<br>Smaller reporting company
Vistagen Therapeutics, Inc.
Sign in to watch- Ticker
- VTGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 205093315
- Phone
- 650-577-3600
- Business address
- 343 ALLERTON AVENUE, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Excaliber Enterprises, Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 51 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-30 | Adler Reid G. CHIEF LEGAL OFFICER | Grant or award | +167 | $1.59 | $265 | 11,488 |
| 2023-06-30 | DOTSON JERROLD DUANE VP, CFO | Grant or award | +167 | $1.59 | $265 | 3,671 |
| 2022-12-30 | DOTSON JERROLD DUANE VP, CFO AND SECRETARY | Grant or award | +5,000 | $0.09 | $438 | 105,111 |
| 2022-12-30 | Singh Shawn CHIEF EXECUTIVE OFFICER | Grant or award | +5,000 | $0.09 | $438 | 158,998 |
| 2022-08-18 | GIN JERRY B Director | Purchase | +100,000 | $0.18 | $18K | 100,000 |
| 2022-08-18 | GIN JERRY B Director | Purchase | +100,000 | $0.18 | $18K | 100,000 |
| 2022-08-17 | Adler Reid G. CHIEF LEGAL OFFICER | Purchase | +300,000 | $0.17 | $51K | 334,629 |
| 2022-08-17 | Singh Shawn CHIEF EXECUTIVE OFFICER | Purchase | +600,000 | $0.17 | $103K | 626,234 |
| 2022-07-30 | DOTSON JERROLD DUANE VP, CFO AND SECRETARY | Grant or award | +5,000 | $0.75 | $4K | 100,111 |
| 2022-07-12 | Venrock Healthcare Capital Partners II, L.P. 10% owner | Sale | −60,000 | $0.89 | $53K | 20,637,286 |
| 2022-06-30 | Singh Shawn CHIEF EXECUTIVE OFFICER | Grant or award | +5,000 | $0.75 | $4K | 153,998 |
| 2022-06-30 | Smith Mark Alan CHIEF MEDICAL OFFICER | Grant or award | +5,000 | $0.75 | $4K | 19,915 |
| 2022-05-12 | Singh Shawn CHIEF EXECUTIVE OFFICER | Option exercise | +100,000 | $1.00 | $100K | 148,998 |
| 2022-05-12 | Singh Shawn CHIEF EXECUTIVE OFFICER | Option exercise · Stock Option (Right to Buy) | −100,000 | 70,000 | ||
| 2022-05-02 | Adler Reid G. CHIEF LEGAL OFFICER | Grant or award · Stock Options (right to buy) | +200,000 | 200,000 | ||
| 2022-03-01 | DOTSON JERROLD DUANE VP, CFO AND SECRETARY | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2022-03-01 | Smith Mark Alan CHIEF MEDICAL OFFICER | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2022-03-01 | Cunningham Ann Michelle CHIEF COMMERCIAL OFFICER | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2022-03-01 | Singh Shawn CHIEF EXECUTIVE OFFICER | Grant or award · Stock Option (Right to Buy) | +300,000 | 300,000 | ||
| 2022-03-01 | GIN JERRY B Director | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 |
Page 4 of 17 · 323 trades